Nearly 90 per cent of cases of cervical cancer are caused by the human papillomavirus (HPV), which spreads primarily through ...

In comparison to the 18% efficacy seen by Gardasil, the efficacy of Cervarix in the naive total vaccinated cohort was 70% against all CIN 2+ regardless of HPV causation, and 30% in the total ...

The next HPV vaccine approved in the United States, called Cervarix, is a bivalent vaccine that protects against HPV types 16 and 18 and was approved for use in females ages 9 to 26. Gardasil 9 ...

More than 200 lawsuits demand warnings on Gardasil labels about an autoimmune disease called Postural Orthostatic Tachycardia Syndrome, or POTS, and Primary Ovarian Insufficiency, or POI ...

GSK says it plans to seek FDA approval for Cervarix by the end of the year. Early studies find that this vaccine, like Gardasil, is extremely safe and effective. GlaxoSmithKline is a WebMD sponsor.

have both been awarded a significant portion of the UNICEF HPV vaccine tender in order to provide the vaccinations. GSK is to provide a supply of Cervarix® (Human Papillomavirus vaccine [Types 16 ...

On the plus side, if GSK can show that Cervarix offers a more durable response than Gardasil, it could make substantial inroads into the latter's market share. As the vaccines market continues to ...